Results 171 to 180 of about 13,840,050 (236)

Laboratory considerations for GRCh37 to GRCh38 reference genome transition: A laboratory quality assurance bulletin of the American College of Medical Genetics and Genomics (ACMG). [PDF]

Genet Med Open
Aggarwal VS, Guha S, Lebo MS, Retterer K, Scharfe C, Bean LJH, ACMG Laboratory Quality Assurance Committee8∗documents@acmg.net.   +6 more
europepmc   +1 more source

Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic. [PDF]

J Immunother Cancer
Eguren-Santamaria I, Melero I, Rodríguez I, Ortego I, Armero M, Galvez-Cancino F, López-Janeiro A, De Andrea CE, F Sanmamed M.   +8 more
europepmc   +1 more source

Mixed Leucocyte Cultures and Histocompatibility Testing

Journal of the Royal College of Physicians of London, 1968
openaire   +2 more sources

pMHChat, characterizing the interactions between major histocompatibility complex class II molecules and peptides with large language models and deep hypergraph learning. [PDF]

Brief Bioinform
Ma J, Wang Z, Tong C, Yang Q, Zhang L, Liu H.   +5 more
europepmc   +1 more source

High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years? [PDF]

J Immunother Cancer
Sondel PM, Rakhmilevich AL, Ansari IH, Erbe AK.   +3 more
europepmc   +1 more source

Histocompatibility testing. I. Probability models for second-set rejection in a "random" population.

, 1968
Regina C. Elandt‐Johnson
openalex   +1 more source

Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples.

J Pharm Bioallied Sci
Ilyas M, Singh A, Gupta PP, Saad T, Singh P, Mishra S, Asati A.   +6 more
europepmc   +1 more source